COQ2 and multiple system atrophy: Recent studies have proposed low CoQ10 levels in cerebrospinal fluid (CSF) as an accurate biomarker for MSA since mutations on the coenzyme Q2 (COQ2) gene and an abnormally low cerebellar CoQ10 concentration have been reported in all MSA patients.